We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. Treasury Department says it is taking steps to curb tax-avoiding inversion deals, but there is little evidence to suggest it will halt the tie-up between New York-based Pfizer and Allergan that will see the former move its headquarters to Dublin. Read More
Horizon Pharma has withdrawn its roughly $1 billion unsolicited bid to acquire specialty pharmaceutical company Depomed after a California judge ruled that Horizon improperly used confidential information. Read More
Sanofi and AstraZeneca are touting an innovative, open model of collaboration that will see the direct exchange of 210,000 compounds between the two companies’ proprietary libraries. Read More
Industry groups are rushing to the aid of Pacira Pharmaceuticals in its ongoing legal battle with the FDA over promotional claims, asking the courts to side with the drugmaker. Read More
The National Health Service of England and the National Institute for Health and Care Excellence have unveiled a proposal that could provide a new pathway for innovative drugs to be assessed and made available to patients. Read More
Pfizer’s proposed merger with Irish drugmaker Allergan is catching flak from some members of Congress who are tying the trend of companies pursuing foreign mergers for tax purposes. Read More
A new report is predicting that spending on prescription and OTC medications will climb 30 percent in the next five years, fueled largely by improved sales and access in emerging markets. Read More
German drugmaker Merck KGaA and Pfizer have received breakthrough therapy designation for immunotherapy avelumab for second-line treatment of metastatic Merkel cell carcinoma. Read More